,,ii  #aah? ,,congress  #a/ ,session    
,s4 #cbai  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,novemb] #b1 #bjbc,ms4 
,baldw9 7= h]self1 ,ms4 ,klobu*>1 ,mr4  
,blum5?al1 & ,ms4 ,smi?7 introduc$ !    
foll[+ bill2 :i* 0 read twice & ref]r$  
to ! ,committee on ,heal?1 ,education1  
,labor1 & ,p5sions  ,a ,,bill  ,to      
protect aga9/ seasonal & p&emic         
influ5za1 & = o!r purposes4  #a4 ,%ort  
title ,?is ,act may be cit$ z !         
,protect+ ,am]ica f ,seasonal & ,p&emic 
,influ5za ,act ( #bjbc or ! ,influ5za   
,act4  #b4 ,f9d+s ,congress f9ds !      
foll[+3 7#a7 ,influ5za occurs seasonally
 ea* ye>1 &1 ?r\gh\t hi/ory1 has caus$  
deva/at+ p&emics4 ,! #aiah influ5za     
p&emic kill$ an e/imat$ #fge1jjj p 9 !  
,unit$ ,/ates4  7#b7 ,9 an av]age       
season1 influ5za results 9 #ab1jjj to   
#eb1jjj dea?s 9 ! ,unit$ ,/ates1 includ+
 ov] #ajj p$iatric dea?s4 ,additionally1
 influ5za causes hundr$s ( ?\s&s (      
hospitalizations & millions ( illnesses4
  7#c7 ,! ,c\ncil ( ,economic ,advisors 

issu$ a report 9 #bjai e/imat+ t        
seasonal influ5za co/s ! ,unit$ ,/ates  
approximately #cfa1jjj1jjj1jjj p] ye>1 &
 t an influ5za p&emic has ! pot5tial to 
cause up to #c1gij1jjj1jjj1jjj 9 losses4
 ,?is report 0 issu$ prior to !         
,,covid-#ai p&emic1 :i* w co/ ! ,unit$  
,/ates an e/imat$ #af1jjj1jjj1jjj1jjj4  
7#d7 ,mo/ fund+ = p&emic influ5za       
prep>$ness up until fiscal ye> #bjah 0  
d]iv$ f supplem5tal appropriations t    
dat$ back to ! #bjji ,h#a,n#a p&emic4   
7#e7 ,c5t]s = ,disease ,control &       
,prev5tion 7ref]r$ to 9 ?is section z ! 
,,cdc7 /udies ( influ5za hospitalization
 rates by race & e?nicity dur+ #aj      
influ5za seasons f #bjji to #bjai %[$ t 
individuals f racial & e?nic m9ority    
gr\ps are at high] risk = be+           
hospitaliz$ ) influ5za4  7#f7 ,!        
,,covid-#ai p&emic response has be5     
built on ! p&emic influ5za response     
ecosy/em4  7#g7 ,/rategies t increase   
seasonal influ5za vacc9ation rates w    
also improve p&emic read9ess4  7#h7 ,!  

,national ,influ5za ,vacc9e             
,mod]nization ,/rategy ( #bjbj-bjcj ( ! 
,dep>tm5t ( ,heal? & ,human ,s]vices    
%\ld be implem5t$ z quickly z possible  
to ensure ! ,nation's vacc9e ent]prise  
is highly responsive1 flexible1         
scalable1 & effective at r$uc+ ! impact 
( seasonal & p&emic influ5za viruses4   
7#i7 ,influ5za surveillance has be5     
improv$ significantly ?r\gh advances 9  
next-g5]ation g5e sequ5c+ tools to      
analyze circulat+ influ5za viruses4 ,!  
te*nology all[s ! ,,cdc to /udy m       
influ5za viruses fa/] & 9 m detail1 & to
 monitor g5etic *anges 9 influ5za       
viruses to bett] und]/& & improve !     
effectiv5ess ( influ5za vacc9es4  7#aj7 
,influ5za diagnosis & surveillance has  
improv$ significantly ?r\gh advances 9  
influ5za te/+4 ,timely infection control
 & prev5tion /rategies w\ld be          
significantly bol/]$ by accurate &      
readily accessible at-home diagno/ic    
te/s4 ,rapid diagno/ics c improve access
 = und]s]v$ populations & all[ = bett]  

antibiotic /ew>d%ip4  7#aa7 ,vacc9e     
hesitancy 9 ! ,unit$ ,/ates has rea*$ a 
tipp+ po9t :]e x is adv]sely affect+    
public heal?4 ,mis9=mation is widely    
available on social m$ia1 & traditional 
s\rces ( in=mation on ! value & efficacy
 ( vacc9es are n tru/$ by _m p ( !      
,unit$ ,/ates1 especially ^? :o are     
vacc9e hesitant4  7#ab7 ,support =      
vacc9e communication1 outrea*1 &        
adm9i/ration across public heal? & heal?
 c>e sett+s is critical to drive dem& ( 
influ5za vacc9es1 treatm5ts1 & m$ical   
c\nt]measures & ensure equitable uptake 
( su* innovations4  #c4 ,/r5g!n+ &      
div]sify+ influ5za vacc9e1 !rapeutics1 &
 diagno/ics developm5t1 manufactur+1 &  
supply *a9  7a7 ,timely deliv]y ( fir/  
doses ( f9i%$ influ5za vacc9e  7#a7     
,national goal ,x is a national goal = !
 ,unit$ ,/ates to h1 n lat] ?an #c ye>s 
aft] ! date ( enactm5t ( ?is ,act1 !    
capacity to deliv] fir/ doses ( f9i%$   
influ5za vacc9e )9 #ab weeks ( em]g5ce (
 an influ5za /ra9 ) p&emic pot5tial4    

7#b7 ,plan ,n lat] ?an #f mon?s aft] !  
date ( enactm5t ( ?is ,act1 ! ,secret>y 
( ,heal? & ,human ,s]vices1 act+ ?r\gh !
 ,assi/ant ,secret>y = ,prep>$ness &    
,response & ! ,director ( ! ,biom$ical  
,advanc$ ,rese>* & ,developm5t          
,au?ority1 %all publi% a plan to a*ieve 
! goal specifi$ 9 p>agraph 7#a74  7b7   
,univ]sal influ5za vacc9e  7#a7         
,national goal ,x is a national goal = !
 ,unit$ ,/ates to h develop$ a univ]sal 
influ5za vacc9e1 n lat] ?an #aj ye>s    
aft] ! date ( enactm5t ( ?is ,act4  7#b7
 ,plan  7,a7 ,publication ,n lat] ?an #a
 ye> aft] ! date ( enactm5t ( ?is ,act1 
! ,secret>y ( ,heal? & ,human ,s]vices1 
act+ ?r\gh ! ,director ( ! ,national    
,in/itutes ( ,heal? & ! ,director ( !   
,biom$ical ,advanc$ ,rese>* &           
,developm5t ,au?ority1 %all publi% a    
plan to a*ieve ! goal specifi$ 9        
p>agraph 7#a7 9 p>tn]%ip ) vacc9e       
manufactur]s4  7,b7 ,int]im support ,!  
plan "u subp>agraph 7,a7 %all include   
provisions1 z necess>y to a*ieve su*    

goal1 = support ov] ! p]iod ( #e ye>s   
foll[+ ! publication ( su* plan ( !     
foll[+3 7i7 ,increm5tal vacc9e efficacy 
improvem5ts4  7ii7 ,! rese>* work=ce4   
7c7 ,/r5g!n+ ! vacc9e supply *a9  7#a7  
,public-private p>tn]%ips  7,a7 ,9 g5]al
 ,! ,secret>y ( ,heal? & ,human ,s]vices
 %all-- 7i7 e/abli% public-private      
p>tn]%ips to /r5g!n ! dome/ic vacc9e    
supply *a92 &  7ii7 evaluate !          
capabilities1 capacity1 & utilization ( 
su* p>tn]%ips1 includ+ by assess+ & te/+
 relevant logi/ical & int]op]able       
te*nology ) /akehold]s 9 ! supply *a94  
7,b7 ,dome/ic vacc9e supply *a9 ,=      
purposes ( ?is p>agraph1 ! t]m dome/ic  
vacc9e supply *a9 includes ! full       
dome/ic supply *a91 includ+-- 7i7       
production ( +r$i5ts & manufactur+ &    
di/ribution ( f9i%$ vacc9es2  7ii7      
fill-f9i% capacity2 &  7iii7 ! supply   
*a9 ( ancill>y supplies su* z ne$les &  
syr+es4  7#b7 ,evaluation ( us+ ,,dpa ,!
 ,secret>y ( ,heal? & ,human ,s]vices1 9
 coord9ation ) ! ,adm9i/rator ( ! ,f$]al

 ,em]g5cy ,managem5t ,ag5cy & !         
,secret>y ( ,def5se1 %all-- 7,a7        
evaluate ! use ( ! ,def5se ,production  
,act ( #aiej 7#ej ,u4,s4,c4 #deja et    
seq47 = ,,covid-#ai p&emic response2    
7,b7 n lat] ?an #a ye> aft] ! date (    
enactm5t ( ?is ,act1 complete su*       
evaluation & submit a report to         
,congress on ! results ( su* evaluation2
 &  7,c7 include 9 su* report-- 7i7     
recomm5dations on us+ ! ,def5se         
,production ,act ( #aiej 7#ej ,u4,s4,c4 
#deja et seq47 = build+ dome/ic capacity
 to respond to an influ5za p&emic2 &    
7ii7 input f ext]nal /akehold]s4  7d7   
,national ,influ5za ,vacc9e             
,mod]nization ,/rategy ,! ,secret>y (   
,heal? & ,human ,s]vices %all-- 7#a7    
implem5t ! portions ( ! ,national       
,influ5za ,vacc9e ,mod]nization ,/rategy
 #bjbj-bjcj t are )9 ! au?ority ( !     
,dep>tm5t ( ,heal? & ,human ,s]vices to 
c>ry out 7"u o!r applicable provisions (
 law72 &  7#b7 by ,june #ae ea* cal5d>  
ye> ?r\gh #bjcj1 submit to ,congress a  

report on su* implem5tation4  7e7       
,assi/ant ,secret>y = ,prep>$ness &     
,response ,section #bhaa ( ! ,public    
,heal? ,s]vice ,act 7#db ,u4,s4,c4      
#cjj;hh-#aj7 is am5d$-- 7#a7 9          
subsection 7b7-- 7,a7 9 p>agraph 7#c71  
by ins]t+ 1 includ+ ! p&emic influ5za   
m$ical c\nt]measures program "u         
p>agraphs 7#b77;,e7 & 7#d77;,h7 (       
section #cai,l7c7 aft] qualifi$ p&emic  
or epidemic products 7z def9$ 9 section 
#cai;,f-#c72 &  7,b7 9 p>agraph 7#g71 9 
! matt] prec$+ subp>agraph 7,a71 by     
ins]t+ 1 includ+ ?r\gh ! p&emic influ5za
 m$ical c\nt]measures program "u        
p>agraphs 7#b77;,e7 & 7#d77;,h7 (       
section #cai,l7c7 aft] = ea* su* ?reat2 
&  7#b7 9 subsection 7d77#b7-- 7,a7 9   
subp>agraph 7,j77v71 by /rik+ & at !    
end2  7,b7 by r$esignat+ subp>agraph    
7,k7 z subp>agraph 7,l72 &  7,c7 by     
ins]t+ aft] subp>agraph 7,j7 ! foll[+3  
7,k7 evaluate progress ) respect to     
implem5t+ ! ,national ,influ5za ,vacc9e 
,mod]nization ,/rategy1 issu$ 9 ,june   

#bjbj1 or any successor /rategy2 &  4   
7f7 ,biom$ical advanc$ rese>* &         
developm5t au?ority  7#a7 ,prep>$ness   
activities ,section #cai,l7c7 ( !       
,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bdg;d-#g;e7c77 is am5d$--    
7,a7 9 p>agraph 7#b7-- 7i7 9 subp>agraph
 7,c71 by /rik+ & at ! end2  7ii7 9     
subp>agraph 7,d71 by /rik+ ! p]iod at ! 
end & ins]t+ 2 &2 &  7iii7 by add+ at ! 
end ( ! foll[+3  7,e7 support+ p&emic   
influ5za c\nt]measure prep>$ness4  2 &  
7,b7 9 p>agraph 7#d71 by add+ at ! end (
 ! foll[+3  7,h7 ,p&emic influ5za m$ical
 c\nt]measures program ,9 c>ry+ out     
p>agraph 7#b77;,e71 ! ,secret>y %all    
e/abli% & implem5t a program t-- 7i7    
supports rese>* & developm5t activities 
= qualifi$ p&emic or epidemic products  
7z def9$ 9 section #cai;,f-#c71 includ+ 
by-- 7,i7 develop+ innovative           
te*nologies to enhance rapid response to
 p&emic influ5za ?reats2  7,,ii7        
develop+ influ5za vacc9es ) pot5tial    
univ]sal vacc9ation capability2  7,,iii7

 develop+ enhanc$ influ5za vacc9es )    
long] la/+ broad spectrum protective    
immunity aga9/ a wid] range (           
antig5ically div]g5t influ5za /ra9s2    
7,,iv7 develop+ alt]native vacc9e       
deliv]y approa*es2  7,v7 develop+ novel 
small- & l>ge-molecule novel influ5za   
antivirals1 monoclonal antibodies1 & o!r
 products t provide bett] influ5za      
treatm5t & prev5tion2  7,,vi7 develop+  
innovative te*nologies to enhance rapid 
diagnosis ( influ5za2 &  7,,vii7        
implem5t+ ! ,national ,influ5za ,vacc9e 
,mod]nization ,/rategy1 issu$ 9 ,june   
#bjbj1 or any successor /rategy2  7ii7  
ensures read9ess to respond to qualifi$ 
p&emic & epidemic ?reats1 includ+ by--  
7,i7 support+ developm5t & manufactur+ (
 influ5za virus se$s1 cl9ical trial     
lots1 & /ockpiles ( novel influ5za      
/ra9s2  7,,ii7 support+ ! /ockpile (    
influ5za antivirals ?r\gh div]sify+ &   
repl5i%+ ! exi/+ /ockpile ( influ5za    
antivirals2  7,,iii7 support+           
manufactur+ & fill-f9i% rapid response  

infra/ructure2  7,,iv7 support+ !       
/ockpile ( influ5za te/+ equipm5t &     
supplies2 &  7,v7 te/+ & evaluat+ p&emic
 ?reat rapid response capabilities ?r\gh
 regul> prep>$ness drills ) key public &
 private sector p>tn]s t exam9e ! range 
( activities 7includ+ production &      
cl9ical te/+ ( influ5za diagno/ics1     
vacc9es1 & !rapeutics7 requir$ to       
effectively respond to novel ?reats2 &  
7iii7 builds1 su/a9s1 & repl5i%es       
qualifi$ p&emic & epidemic /ockpiles (  
bulk antig5 & adjuvant mat]ial1 includ+ 
by-- 7,i7 annually te/+ ! pot5cy &      
%elflife pot5tial ( all exi/+ p&emic &  
epidemic /ockpiles held by ! ,dep>tm5t (
 ,heal? & ,human ,s]vices2 &  7,,ii7    
develop+1 & dissem9at+ to key public &  
private sector p>tn]s1 a life cycle     
managem5t plan4  4  7g7 ,au?orization ( 
appropriations ,section #cai,l7d7 ( !   
,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bdg;d-#g;e7d77 is am5d$ by   
add+ at ! end ! foll[+3  7#c7 ,p&emic   
influ5za ,to c>ry out ?is section &     

section #bhaa ) respect to p&emic       
influ5za1 9 addition to am\nts au?oriz$ 
to be appropriat$ by p>agraph 7#b7 & any
 am\nts au?oriz$ to be appropriat$ by   
section #bhaa1 !re is au?oriz$ to be    
appropriat$ #cce1jjj1jjj = ea* ( fiscal 
ye>s #bjbd ?r\gh #bjbh1 to rema9        
available until exp5d$4  4  #d4 ,promot+
 innovative approa*es & use ( new       
te*nologies to detect1 prev5t1 & respond
 to influ5za  7a7 ,s5se ( ,congress ,x  
is ! s5se ( ,congress t ! ,c5t]s =      
,disease ,control & ,prev5tion %\ld     
support int]op]able immunization        
in=mation sy/ems t enable bidirectional 
data ex*ange among ,/ates1 localities1 &
 community immunization provid]s4  7b7  
,prioritiz+ influ5za1 influ5za          
comb9ation1 & pa?og5 agno/ic tools  7#a7
 ,,nih ,! ,director ( ! ,national       
,in/itutes ( ,heal? may conduct or      
support basic rese>* prioritiz+ !       
developm5t (-- 7,a7 agno/ic tools to    
detect influ5za & o!r pa?og5s2 &  7,b7  
te*nologies t automate sample prep>ation

 = su* tools4  7#b7 ,,b>da ,! ,director 
( ! ,biom$ical ,advanc$ ,rese>* &       
,developm5t ,au?ority may conduct or    
support advanc$ developm5t ( novel      
sequ5c+ modalities prioritiz+ tools     
describ$ 9 p>agraph 7#a77;,a7 &         
te*nologies describ$ 9 p>agraph         
7#a77;,b74  7c7 ,developm5t (           
po9t-(-,c>e & self-,te/+ diagno/ics ,!  
,director ( ! ,biom$ical ,advanc$       
,rese>* & ,developm5t ,au?ority1 9      
collaboration ) ! ,director ( ! ,c5t]s =
 ,disease ,control & ,prev5tion1 !      
,director ( ! ,national ,in/itutes (    
,heal?1 & ! ,commission] ( ,food &      
,drugs1 may conduct or support          
developm5t ( rapid1 accurate1 easily    
accessible1 self-adm9i/rable diagno/ic  
te/s t are readable at ! po9t ( c>e or  
at home4  7d7 ,incorporat+ diagno/ics   
supply *a9 resili5cy into influ5za      
p&emic plann+ ,! ,assi/ant ,secret>y =  
,prep>$ness & ,response1 9 collaboration
 ) ! ,commission] ( ,food & ,drugs1 !   
,director ( ! ,c5t]s = ,disease ,control

 & ,prev5tion1 ! ,secret>y ( ,comm]ce1 &
 ! ,secret>y ( ,transportation1 %all--  
7#a7 incorporate diagno/ics supply *a9  
resili5cy into influ5za p&emic plann+ t 
supports a heal? c>e sy/em t te/s to    
treat & bol/]s te/+ & vacc9e deliv]y    
supply *a9s2 &  7#b7 n lat] ?an #a ye>  
aft] ! date ( enactm5t ( ?is ,act1      
publi% a plan = rapidly exp&+ public &  
private diagno/ic te/+ capacity 7includ+
 at cl9ical laboratories1 at public     
heal? dep>tm5t laboratories1 & by means 
( self-te/+7 9 an influ5za p&emic1      
includ+ address+ transportation         
infra/ructure1 ! ne$ = /]ilization1 &   
s\rc+ critical raw mat]ials1 compon5ts1 
& p>ts4  7e7 ,scal+ up prophylactic     
influ5za antibody products t address    
gaps 9 cov]age ,! ,director ( !         
,biom$ical ,advanc$ ,rese>* &           
,developm5t ,au?ority may conduct or    
support prev5tive approa*es1 includ+ ^? 
/ill 9 precl9ical & cl9ical /ages1 to   
rapidly scale up preexposure            
prophylactic influ5za antibody products 

t address influ5za infection4  7f7      
,mod]niz+ pot5cy assays ,! ,commission] 
( ,food & ,drugs %all "w ) vacc9e       
manufactur]s to mod]nize pot5cy assays  
across a v>iety ( manufactur+           
te*nologies s z to r$uce by #f weeks !  
p]iod requir$ to fir/ evaluate new      
vacc9e c&idates dur+ a p&emic4  7g7     
,improv$ influ5za !rapeutics ,!         
,director ( ! ,biom$ical ,advanc$       
,rese>* & ,developm5t ,au?ority may     
conduct or support improv$ influ5za     
!rapeutics t-- 7#a7 are m broadly       
protective2 &  7#b7 meet ! ne$s (       
high-risk & high-exposure pati5ts4  #e4 
,increas+ influ5za vacc9e1 !rapeutics1 &
 te/+ access & cov]age across all       
populations  7a7 ,annual report on      
public communication /rategy ,!         
,director ( ! ,c5t]s = ,disease ,control
 & ,prev5tion %all submit an annual     
report to ,congress on ! public         
communication /rategy ( ! ,c5t]s to     
increase public confid5ce 9 ! safety &  
effectiv5ess ( vacc9es4  7b7 ,s5se (    

,congress ,x is ! s5se ( ,congress t !  
,director ( ! ,national ,in/itutes (    
,heal?1 ! ,director ( ! ,c5t]s =        
,disease ,control & ,prev5tion1 !       
,secret>y ( ,def5se1 ! ,secret>y (      
,vet]ans ,affairs1 ! ,adm9i/rator ( !   
,c5t]s = ,m$ic>e  ,m$icaid ,s]vices1 & !
 ,commission] ( ,food & ,drugs %\ld     
support rese>* us+ l>ge data sets f     
multiple s\rces ( heal? data to fur!r   
support & evaluate vacc9e safety &      
effectiv5ess ov] multiple influ5za      
seasons4  7c7 ,address+ mis9=mation &   
dis9=mation  7#a7 ,9 g5]al ,! ,secret>y 
( ,heal? & ,human ,s]vices %all create  
p>tn]%ips to address mis9=mation &      
dis9=mation ) respect to influ5za       
vacc9es4  7#b7 ,requirem5ts ,! p>tn]%ips
 "u p>agraph 7#a7 %all-- 7,a7 build on  
lessons le>n$ f ,,covid-#ai2 &  7,b7    
all[ = dissem9ation ( be/ practices &   
lessons le>n$ betwe5 p>tn]+             
organizations4  7#c7 ,memb]s ,! memb]s (
 ! p>tn]%ips "u p>agraph 7#a7 %all      
include repres5tatives ( organizations )

 exp]i5ce work+ ) vuln]able populations1
 includ+-- 7,a7 individuals ) *ronic    
heal? conditions2  7,b7 old]            
individuals2  7,c7 p>5ts ( "y *ildr52   
7,d7 pregnant p2  7,e7 ,tribal          
communities2 &  7,f7 racial & e?nic     
m9orities4  7#d7 ,conf]r+ ) p>tn]+      
organizations ,! ,secret>y ( ,heal? &   
,human ,s]vices %all conf] )            
organizations repres5t$ 9 p>tn]%ips "u  
p>agraph 7#a7-- 7,a7 9 advance ( ea*    
seasonal influ5za season1 on messag+ &  
communications2 &  7,b7 at ! end ( ea*  
seasonal influ5za season1 on be/        
practices & lessons le>n$4  7#e7 ,report
 to ,congress ,n lat] ?an "o ye> aft] ! 
date ( enactm5t ( ?is ,act1 ! ,secret>y 
( ,heal? & ,human ,s]vices %all report  
to ,congress on ! p>tn]%ips creat$1 &   
activities conduct$1 "u ?is section4    
7d7 ,communications public-,private     
p>tn]%ip  7#a7 ,9 g5]al ,n lat] ?an #f  
mon?s aft] ! date ( enactm5t ( ?is ,act1
 ! ,secret>y ( ,heal? & ,human ,s]vices 
%all implem5t a t>get$ demon/ration     

project t provides = ! e/abli%m5t ( a   
communications public-private p>tn]%ip  
initiative = increas+ vacc9e confid5ce4 
7#b7 ,requirem5ts ,! demon/ration       
project "u p>agraph 7#a7 %all-- 7,a7 be 
implem5t$ ?r\gh an indep5d5t1           
nongov]nm5tal1 nonpr(it entity2  7,b7   
focus on individuals ) *ronic illness or
 o!r comorbidities :o t5d to h worse    
cl9ical outcomes f influ5za 7su* z      
individuals ) he>t disease or diabetes1 
& racial & e?nic m9orities72  7,c7      
support behavioral rese>* ar\nd s\rces (
 vacc9e hesitancy2 &  7,d7 develop &    
implem5t a t>get$1 multimodal           
communications campaign1 us+ int]net    
plat=ms1 television1 & nontraditional   
t>get$ social m$ia & community outrea* 9
 an ef=t to rea* individuals :o may be  
especially vacc9e hesitant4  7#c7       
,report ,n lat] ?an #f mon?s aft]       
completion ( ! demon/ration project "u  
p>agraph 7#a71 ! ,secret>y ( ,heal? &   
,human ,s]vices %all-- 7,a7 prep>e a    
report on ! demon/ration project1       

includ+ an evaluation ( ! project's     
me?ods1 f9d+s1 & results2 &  7,b7 make  
su* report publicly available on !      
website ( ! ,dep>tm5t ( ,heal? & ,human 
,s]vices4  7e7 ,incorporat+ heal? equity
 into seasonal & p&emic influ5za plann+ 
& response ,! ,director ( ! ,c5t]s =    
,disease ,control & ,prev5tion & !      
,assi/ant ,secret>y = ,prep>$ness &     
,response %all-- 7#a7 incorporate heal? 
equity into ! seasonal & p&emic influ5za
 plann+ & response programs ov]se5 by   
su* (ficials2 &  7#b7 9 s do+-- 7,a7    
emphasize ! inclusion ( all populations2
 &  7,b7 include /rategies to rea*      
communities ( color1 communities ) l[]  
socioeconomic /atus1 s5iors1 &          
individuals ) disabilities1 includ+     
address+ b>ri]s to vacc9ations1         
!rapeutics1 & diagno/ics 9 ! po9t-(-c>e 
& at-home self-te/+ sett+s4  7f7 ,exp&+ 
access to influ5za treatm5t & adopt+    
lessons le>n$ f ,,covid-#ai ,f$]al      
,retail ,ph>macy ,program  7#a7 ,report 
,n lat] ?an #f mon?s aft] ! date (      

enactm5t ( ?is ,act1 ! ,secret>y (      
,heal? & ,human ,s]vices %all submit a  
report to ! ,congress on lessons le>n$ f
 ! ,,covid-#ai ,f$]al ,retail ,ph>macy  
,program1 includ+ aspects ( ! program t 
c\ld be appli$ ) respect to multianalyte
 te/s t t>get ,,covid-#ai z well z      
influ5za & o!r upp] respiratory viruses4
  7#b7 ,demon/ration project  7,a7 ,9   
g5]al ,n lat] ?an "o ye> aft] ! date (  
enactm5t ( ?is ,act1 ! ,secret>y (      
,heal? & ,human ,s]vices %all initiate  
an influ5za te/-to-treat demon/ration   
project t builds on ! te/-to-treat model
 employ$ = ,,covid-#ai4  7,b7 ,l5g?2    
locations ,?is demon/ration project "u  
subp>agraph 7,a7 %all run = ! l5g? ( "o 
seasonal influ5za season & be bas$ 9 "o 
or m ( ! foll[+ locations3 7i7          
,facilities t s]ve vuln]able            
populations1 su* z populations :o are 9 
long-t]m c>e facilities1 are #fe ye>s ( 
age or old]1 may h o!r m$ical           
conditions1 & w be 9 unavoidable close  
contact ) o!rs4  7ii7 ,f$]al heal? c>e  

facilities t s]ve at-risk & vuln]able   
communities1 su* z ,indian ,heal?       
,s]vice cl9ics1 ,f$]ally qualifi$ heal? 
c5t]s 7z def9$ 9 section #ahfa7;aa7 ( ! 
,social ,security ,act 7#db ,u4,s4,c4   
#aciex7aa7771 & facilities ( ! ,dep>tm5t
 ( ,vet]ans ,affairs4  7iii7 ,exi/+     
,,covid-#ai te/-to-treat sites at retail
 ph>macies1 pot5tially 9 specific       
geographic areas ) hi/orically high     
mortality f influ5za4  7iv7 ,o!r        
appropriate locations id5tifi$ by !     
,secret>y ( ,heal? & ,human ,s]vices1 9 
consultation ) ext]nal /akehold]        
organizations1 to te/ ! op]ational      
feasibility & impact ( influ5za         
te/-to-treat programs4  7#c7 ,report ,n 
lat] ?an #f mon?s aft] completion ( !   
demon/ration project "u p>agraph 7#b71 !
 ,secret>y ( ,heal? & ,human ,s]vices   
%all-- 7,a7 prep>e a report on !        
demon/ration project "u p>agraph 7#b71  
includ+ an evaluation ( ! project's     
me?ods1 f9d+s1 & results2 &  7,b7 make  
su* report publicly available on !      

website ( ! ,dep>tm5t ( ,heal? & ,human 
,s]vices4  7g7 ,creat+ adm9i/ration     
pa?ways ,! ,secret>y ( ,heal? & ,human  
,s]vices may aw>d grants to ,/ates to   
create adm9i/ration pa?ways = ph>macy   
p]sonnel to adm9i/] influ5za vacc9es1   
te/s1 & !rapeutics1 9 ord] to increase  
vacc9ation1 te/+1 & relevant treatm5t z 
ne$$ = adults & *ildr54  7h7 ,/rategic  
,national ,/ockpile ,! ,secret>y (      
,heal? & ,human ,s]vices %all           
incorporate into ! ,/rategic ,national  
,/ockpile "u section #cai;,f-#b ( !     
,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bdg;d-#f;b7 products ne$$ to 
respond to p&emic influ5za1 includ+     
?r\gh-- 7#a7 dynamic managem5t (        
antivirals2  7#b7 v5dor-manag$ inv5tory 
( te/+ equipm5t & supplies2  7#c7       
repl5i%m5t ( ag+ antivirals1 te/+       
equipm5t1 supplies1 & o!r products2 &   
7#d7 div]sification ( /ockpil$ products4
  7i7 ,monitor+ & di/ribut+ influ5za    
antiviral supplies ,! ,secret>y ( ,heal?
 & ,human ,s]vices %all-- 7#a7 monitor  

influ5za antiviral supplies ?r\gh\t !   
c\ntry & publicly report *all5ges 9     
availability 9 any region1 ,/ate1 c\nty1
 or metropolitan area2 &  7#b7 e/abli% a
 process1 to be us$ 9 ! case ( a p&emic 
or dur+ times :5 influ5za antiviral     
supply availability is *all5g$1 to      
ensure rapid & effective di/ribution (  
products to areas ( urg5t ne$ 9 close   
coord9ation ) manufactur]s1 di/ributors1
 & ,/ate & local heal? (ficials4  7j7   
,plan = ensur+ access to appropriate    
influ5za !rapeutics1 preexposure        
prophylaxis1 & diagno/ics  7#a7 ,9 g5]al
 ,n lat] ?an #a ye> aft] ! date (       
enactm5t ( ?is ,act1 ! ,secret>y (      
,heal? & ,human ,s]vices %all publi% a  
plan = ensur+ access to appropriate     
influ5za !rapeutics1 preexposure        
prophylaxis influ5za antibody products1 
& influ5za diagno/ics1 includ+ dur+     
times :5 availability is *all5g$ 9 c]ta9
 regions or localities1 =-- 7,a7        
high-risk pati5ts1 su* z nurs+ home &   
p$iatric pati5ts2  7,b7 high-exposure   

pati5ts1 su* z fir/ respond]s & heal?   
c>e work]s2 &  7,c7 l[-income           
individuals1 individuals cov]$ "u !     
,m$icaid program "u title ,,xix ( !     
,social ,security ,act 7#db ,u4,s4,c4   
#acif et seq471 un9sur$ individuals1    
,tribal communities1 & o!r und]s]v$     
populations4  7#b7 ,communications ef=ts
 ,! plan requir$ by p>agraph 7#a7 %all  
include communications ef=ts to educate 
! public ab\t ! b5efits ( e>ly use (    
influ5za diagno/ics1 !rapeutics4 &      
preexposure prophylaxis products4  7k7  
,,gao review on transf]r+ ,,covid-#ai   
te*nologies  7#a7 ,9 g5]al ,n lat] ?an  
#f mon?s aft] ! date ( enactm5t ( ?is   
,act1 ! ,comptroll] ,g5]al ( ! ,unit$   
,/ates %all conduct a review ( !        
te*nology & sy/ems utiliz$ by ! ,c5t]s =
 ,disease ,control & ,prev5tion1 !      
,adm9i/ration = ,/rategic ,prep>$ness & 
,response1 ,op]ation ,w>p ,spe$1 !      
,c\nt]measure ,accel]ation ,gr\p1       
,h-,,core1 & o!r curr5t & hi/orical     
dep>tm5ts & ag5cies involv$ 9 !         

,,covid-#ai response = surveillance &   
track+ ( ,,covid-#ai cases1 treatm5ts1 &
 vacc9es1 ) p>ticul> focus on-- 7,a7    
disease surveillance2  7,b7 vacc9e      
surveillance2 &  7,c7 vacc9e            
effectiv5ess4  7#b7 ,scope ,! review "u 
p>agraph 7#a7 %all include-- 7,a7       
assessm5t ( :i* te*nology & sy/ems c be 
appli$ to1 or c be alt]$ to apply to1   
influ5za & o!r infecti\s diseases2 &    
7,b7 =mulation ( recomm5dations = apply+
 & alt]+ te*nologies & sy/ems z describ$
 9 subp>agraph 7,a74  7#c7 ,report by   
,,hhs to ,congress ,n lat] ?an #cj days 
aft] completion ( ! review requir$ by   
p>agraph 7#a71 ! ,secret>y ( ,heal? &   
,human ,s]vices %all submit a report to 
,congress on ! timel9e & actions        
necess>y to implem5t ! recomm5dations   
=mulat$ "u p>agraph 7#b77;,b74  #f4     
,au?oriz+ su/a9able fund+ = ! influ5za  
ecosy/em  7a7 ,influ5za ,plann+ &       
,response ,program ,!re is au?oriz$ to  
be appropriat$ #bca1jjj1jjj = fiscal ye>
 #bjbd & ea* subsequ5t fiscal ye> =     

programs & activities ( ! ,c5t]s =      
,disease ,control & ,prev5tion relat+ to
 influ5za plann+ & response4  7b7       
,/rategic ,national ,/ockpile ,!re is   
au?oriz$ to be appropriat$ #ife1jjj1jjj 
= fiscal ye> #bjbd & ea* subsequ5t      
fiscal ye> = ! ,/rategic ,national      
,/ockpile "u section #cai;,f-#b ( !     
,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bdg;d-#f;b74  7c7 ,hospital  
,prep>$ness ,program ,!re is au?oriz$ to
 be appropriat$ #cje1jjj1jjj = fiscal   
ye> #bjbd & ea* subsequ5t fiscal ye> =  
,hospital ,prep>$ness ,program ( !      
,assi/ant ,secret>y = ,prep>$ness &     
,response4  7d7 ,univ]sal ,flu ,vacc9e  
,rese>* ,!re is au?oriz$ to be          
appropriat$ #bgj1jjj1jjj = fiscal ye>   
#bjbd & ea* subsequ5t fiscal ye> =      
rese>* ( ! ,national ,in/itutes ( ,heal?
 to develop a univ]sal flu vacc9e4  7e7 
,immunization ,program ,!re is au?oriz$ 
to be appropriat$ #fhb1jjj1jjj = fiscal 
ye> #bjbd & ea* subsequ5t fiscal ye> = !
 immunization program ( ! ,c5t]s =      

,disease ,control & ,prev5tion "u       
section #cag ( ! ,public ,heal? ,s]vice 
,act 7#db ,u4,s4,c4 #bdg;b74  7f7       
,public ,heal? ,em]g5cy ,prep>$ness     
,program ,!re is au?oriz$ to be         
appropriat$ #gce1jjj1jjj = fiscal ye>   
#bjbd & ea* subsequ5t fiscal ye> = !    
,public ,heal? ,em]g5cy ,prep>$ness     
,program ( ! ,c5t]s = ,disease ,control 
& ,prev5tion4  7g7 ,infecti\s ,disease  
,rapid ,response ,res]ve ,fund ,!re is  
au?oriz$ to be appropriat$ #ce1jjj1jjj =
 fiscal ye> #bjbd & ea* subsequ5t fiscal
 ye> = ! ,infecti\s ,disease ,rapid     
,response ,res]ve ,fund ( ! ,c5t]s =    
,disease ,control & ,prev5tion4  7h7    
,data ,mod]nization ,initiative ,!re is 
au?oriz$ to be appropriat$ #age1jjj1jjj 
= fiscal ye> #bjbd & ea* subsequ5t      
fiscal ye> = ! ,public ,heal? ,data     
,mod]nization ,initiative ( ! ,c5t]s =  
,disease ,control & ,prev5tion4